TGM2 and epilepsy: Specifically, viral‐mediated TGM2 overexpression (AAV‐Tgm2) and knockdown (shTgm2) models were established, and TGM2 overexpression prolonged the latency period and reduced the frequency of seizures, whereas TGM2 knockdown exacerbated epilepsy progression.